Displaying items by tag: division of maternal fetal medicine

Results from the Chronic Hypertension and Pregnancy trial found treating preexisting mild chronic hypertension in pregnant women is safe from both the mom and baby. Results published in April 2022 have since led to changes in national guidelines.
Preeclampsia is a leading cause of maternal mortality. Brian Brocato, D.O., UAB maternal-fetal medicine specialist, discusses the signs, symptoms and treatment of the pregnancy condition.
Ashton Ayers was not expected to survive after an accident left her with a traumatic brain injury during her freshman year of high school. A decade later, Ayers defied the odds and graduated from the UAB School of Nursing.
Six months after giving birth to identical twins, Britney Alba found out she was pregnant with her second set of identical twins. These twins, however, were monochorionic-monoamniotic — one of the rarest types of twins.
Findings show a single oral dose of azithromycin, a common antibiotic, reduced the risk of maternal sepsis or death by 33 percent in women who delivered vaginally.
Pelvic floor therapy provides a conservative and holistic approach to pelvic floor dysfunction, but many women do not know about the treatment. JJ Fagen, UAB Medicine’s pelvic floor therapist, discusses the benefits of pelvic floor therapy and pelvic floor exercises
Cord blood from a newborn’s umbilical cord can be used to treat many types of blood cancers such as leukemia.
UAB women’s health experts found that prophylactic anticoagulation guidelines did not reduce risk of venous thromboembolisms but did increase the risk for bleeding complications in the general obstetric population.
UAB-led national study shows using blood pressure medication to treat pregnant women with chronic hypertension improves pregnancy outcomes, including a decrease in severe preeclampsia and preterm birth.
UAB maternal-fetal medicine specialists partner with the DCH Health System to provide specialized care for high-risk pregnancy patients in West Alabama.
Consortium led by UAB researchers in the UAB Heersink School of Medicine and School of Public Health received additional funding to further study chronic hypertension and preeclampsia epigenetics participants enrolled in the CHAP trial.
Page 1 of 3